Filtered By:
Education: New York University
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 45 results found since Jan 2013.
Global research trends on COVID-19 and stroke: A bibliometric analysis
ConclusionOur bibliometric analysis provides a comprehensive overview of the current state of research on COVID-19 and stroke and highlights key areas of focus in the field. Optimizing the treatment of COVID-19-infected stroke patients and elucidating the underlying pathogenic mechanisms of COVID-19 and stroke co-morbidity are key areas of future research that will be beneficial in improving the prognosis of stroke patients during the ongoing COVID-19 epidemic.
Source: Frontiers in Neurology - April 3, 2023 Category: Neurology Source Type: research
Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study
by Fen Wu, Karen L. Koenig, Anne Zeleniuch-Jacquotte, Saran Jonas, Yelena Afanasyeva, Oktawia P. Wójcik, Max Costa, Yu Chen
Background Taurine (2-aminoethanesulfonic acid), a conditionally essential sulfur-containing amino acid, is mainly obtained from diet in humans. Experimental studies have shown that taurine’s main biological actions include bile salt conjugation, blood pressure regulation, anti-oxidation, and anti-inflammation. Methods We conducted a prospective case-control study nested in the New York University Women’s Health Study, a cohort study involving 14,274 women enrolled since 1985. Taurine was measure...
Source: PLoS One - February 11, 2016 Category: Biomedical Science Authors: Fen Wu et al. Source Type: research
Here ’s Why Aspirin Is Important for Preventing Heart Disease
By now, it’s not a surprise that doctors advise anyone who has had a heart attack or stroke to take a low-dose aspirin every day. But remembering to take a pill daily can be a challenge.
In a new study published Monday in the journal Circulation, researchers show just how risky stopping aspirin therapy can be. They followed more than 601,000 people who took low-dose aspirin (80mg) daily to prevent heart disease and stroke. Three years after the study began, people who stopped taking aspirin for whatever reason had a 37% higher rate of heart problems including heart attack and stroke, compared to those who continued r...
Source: TIME.com: Top Science and Health Stories - September 25, 2017 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized aspirin aspirin and heart disease onetime Stroke Source Type: news
Why It ’s So Risky for Heart Patients to Stop Taking a Daily Aspirin
By now, it’s not a surprise that doctors advise anyone who has had a heart attack or stroke to take a low-dose aspirin every day. But remembering to take a pill daily can be a challenge.
In a new study published Monday in the journal Circulation, researchers show just how risky stopping aspirin therapy can be. They followed more than 601,000 people who took low-dose aspirin (80mg) daily to prevent heart disease and stroke. Three years after the study began, people who stopped taking aspirin for whatever reason had a 37% higher rate of heart problems including heart attack and stroke, compared to those who continued r...
Source: TIME.com: Top Science and Health Stories - September 25, 2017 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized aspirin aspirin and heart disease onetime Stroke Source Type: news
Hispanic individuals benefit from skills-based stroke prevention intervention
(New York University) A culturally tailored program used when discharging stroke patients from the hospital helped to lower blood pressure among Hispanic individuals one year later, finds a new study led by researchers at NYU College of Global Public Health. The almost 10 mm Hg reduction in systolic blood pressure measured in this study has been linked to a nearly 40-percent reduction in the risk of having another stroke in previous studies.
Source: EurekAlert! - Medicine and Health - October 8, 2018 Category: International Medicine & Public Health Source Type: news
Disappearing bacterium may protect against stroke
(NYU Langone Medical Center / New York University School of Medicine) A new study by NYU School of Medicine researchers reveals that an especially virulent strain of the gut bacterium Helicobacter pylori isn't implicated in the overall death rate of the US population, and may even protect against stroke and some cancers.
Source: EurekAlert! - Medicine and Health - January 9, 2013 Category: Global & Universal Source Type: news
A good night's sleep and regular exercise 'significantly cuts risk of stroke'
Experts found sleeping for seven to eight hours and taking 30 to 60 minutes of exercise three to six times a week was optimal
Source: Telegraph Health - February 18, 2016 Category: Consumer Health News Tags: obese New York University School of Medicine stroke exercise sleeping Source Type: news
VIDEO: Rapidly improving stroke patients still at risk for bad outcomes
LOS ANGELES – Stroke patients might seem to improve on their way to the hospital, but it’s hard to know if they really are.
Investigators at State University of New York, Brooklyn, have taken a...
Source: Hospitalist News - February 25, 2016 Category: Hospital Management Source Type: research
Robotic arm may help to rehabilitate chronic stroke victims, finds new study
(New York University) New research published in Frontiers in Neurology by NYU researcher Adam Buchwald finds that robotic arm rehabilitation in chronic stroke patients with aphasia, the loss of ability to understand or express speech, may promote speech and language function recovery.
Source: EurekAlert! - Medicine and Health - October 29, 2018 Category: International Medicine & Public Health Source Type: news
Comparison of the Effect of Atrial Fibrillation Detection Algorithms in Patients with Cryptogenic Stroke Using Implantable Loop Recorders
Occult atrial fibrillation (AF) can be the underlying cause for cryptogenic stroke (CS). Implantable loop recorders (ILRs) have become an important tool for long-term arrhythmia monitoring in CS patients. Office-based ILR implantation by non-electrophysiologist physicians is increasingly common. To report the real world diagnostic yield and accuracy of remote ILR monitoring in high risk CS patients, we retrospectively analyzed 145 consecutive patients with CS who underwent ILR implantation between October 2014 and October 2018 at New York University Langone Health.
Source: The American Journal of Cardiology - May 21, 2020 Category: Cardiology Authors: Ehud Chorin, Connor Peterson, Edward Kogan, Chirag Barbhaiya, Anthony Aizer, Douglas Holmes, Scott Bernstein, Michael Schole, Harish Duraiswami, Michael Spinelli, David Park, Larry Chinitz, Lior Jankelson Source Type: research
NYU Dentistry awarded $1.9M NIH grant to study mitochondrial changes behind stroke, heart attack
(New York University) The National Institute of General Medical Sciences, part of the National Institutes of Health (NIH), has awarded NYU College of Dentistry's Evgeny Pavlov a grant to study a phenomenon called mitochondrial permeability transition, one of the central causes of tissue damage during stroke and heart attack.
Source: EurekAlert! - Biology - February 1, 2021 Category: Biology Source Type: news
Report: Extra insights, but no clear-cut answers from TAVR embolic protection studies
Data from two new studies has provided extra insights, but no clear-cut solution for predicting stroke and which patients should receive embolic protection devices during transcatheter aortic valve replacement procedures, according to a new Medscape report.
Results from a meta-analysis of 1,285 patients indicated that the use of embolic protection devices during TAVR procedures did not reduce mortality, but was associated with a lowered rate of stroke at 30 days, according to the report.
The decline was mainly driven by registry data and was not confirmed by randomized controlled trials, Medscape specified.
Stroke was repo...
Source: Mass Device - May 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Claret Medical Inc. Source Type: news
Functional MRI of Letter Cancellation Task Performance in Older Adults
Conclusion
The present work is the first to identify neural correlates of the LCT using fMRI and tablet technology in a healthy aging population. Across all ages, the activation was found to be bilateral, including in the cerebellum, superior temporal lobe, precentral gyrus, frontal gyrus, and various occipital and parietal areas. With increasing age, performance generally decreased and brain activity was reduced in the supplementary motor area, middle and inferior frontal gyrus, middle occipital gyrus, putamen and cerebellum. Better LCT performance was correlated with increased activity in the middle frontal gyrus, and r...
Source: Frontiers in Human Neuroscience - April 15, 2019 Category: Neuroscience Source Type: research
J & J ’ s Biosense Webster launches WaveCrest study
Johnson & Johnson‘s (NYSE:JNJ) Biosense Webster said today that the first patient has been enrolled in an investigational device exemption trial for its WaveCrest system.
The 1,250-patient study is designed to assess the safety and efficacy of the WaveCrest left atrial appendage occlusion system as a way to reduce the risk of embolic stroke in atrial fibrillation patients.
“The WaveCrest System is designed to enable physicians to close the heart’s LAA, where most stroke-causing blood clots occur,” Dr. Larry Chinitz, who treated the first patient in the trial at New York University Hospital, s...
Source: Mass Device - January 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials BioSense Webster Inc. johnsonandjohnson Source Type: news
